On 2025-05-13, AN2 Therapeutics, Inc. (ANTX) announced earnings per share of $-0.35 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.26.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.31 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.26 | $-0.35 |
| 2025-03-25 | 2024-12-31 | $-0.25 | $-0.25 |
| 2024-11-13 | 2024-09-30 | $-0.37 | $-0.43 |
| 2024-08-13 | 2024-06-30 | $-0.63 | $-0.48 |
| 2024-05-14 | 2024-03-31 | $-0.61 | $-0.56 |
| 2024-03-28 | 2023-12-31 | $-0.71 | $-0.57 |
| 2023-11-09 | 2023-09-30 | $-0.63 | $-0.65 |
| 2023-08-10 | 2023-06-30 | $-0.85 | $-0.81 |
| 2023-05-11 | 2023-03-31 | $-0.68 | $-0.79 |
| 2023-03-29 | 2022-12-31 | $-0.63 | $-0.61 |
| 2022-11-09 | 2022-09-30 | $-0.59 | $-0.59 |
| 2022-08-11 | 2022-06-30 | $-0.45 | $-0.53 |
| 2022-05-10 | 2022-03-31 | $-0.52 | $-2.98 |